» Articles » PMID: 36373825

Plasma Metabolites Link Dietary Patterns to Stroke Risk

Abstract

Objective: While dietary intake is linked to stroke risk, surrogate markers that could inform personalized dietary interventions are lacking. We identified metabolites associated with diet patterns and incident stroke in a nested cohort from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Methods: Levels of 162 metabolites were measured in baseline plasma from stroke cases (n = 1,198) and random controls (n = 904). We examined associations between metabolites and a plant-based diet pattern previously linked to reduced stroke risk in REGARDS. Secondary analyses included 3 additional stroke-associated diet patterns: a Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Southern diet. Metabolites were tested using Cox proportional hazards models with incident stroke as the outcome. Replication was performed in the Jackson Heart Study (JHS). Inverse odds ratio-weighted mediation was used to determine whether metabolites mediated the association between a plant-based diet and stroke risk.

Results: Metabolites associated with a plant-based diet included the gut metabolite indole-3-propionic acid (β = 0.23, 95% confidence interval [CI] [0.14, 0.33], p = 1.14 × 10 ), guanosine (β = -0.13, 95% CI [-0.19, -0.07], p = 6.48 × 10 ), gluconic acid (β = -0.11, 95% CI [-0.18, -0.04], p = 2.06 × 10 ), and C7 carnitine (β = -0.16, 95% CI [-0.24, -0.09], p = 4.14 × 10 ). All of these metabolites were associated with both additional diet patterns and altered stroke risk. Mediation analyses identified guanosine (32.6% mediation, p = 1.51 × 10 ), gluconic acid (35.7%, p = 2.28 × 10 ), and C7 carnitine (26.2%, p = 1.88 × 10 ) as mediators linking a plant-based diet to reduced stroke risk.

Interpretation: A subset of diet-related metabolites are associated with risk of stroke. These metabolites could serve as surrogate markers that inform dietary interventions. ANN NEUROL 2023;93:500-510.

Citing Articles

Targeted Metabolomics in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Ament Z, Kijpaisalratana N, Bhave V, Couch C, Garcia Guarniz A, Patki A Sci Data. 2025; 12(1):395.

PMID: 40050322 PMC: 11885657. DOI: 10.1038/s41597-025-04746-x.


The effect of L-carnitine supplementation on anthropometric and malnutrition status in acute ischemic stroke patients: a triple-blinded randomized clinical trial.

Hajjarzadeh S, Zarei M, Rafie S, Shalilahmadi D, Karandish M BMC Nutr. 2025; 11(1):20.

PMID: 39849647 PMC: 11758746. DOI: 10.1186/s40795-025-01008-2.


Towards the prediction of drug solubility in binary solvent mixtures at various temperatures using machine learning.

Bao Z, Tom G, Cheng A, Watchorn J, Aspuru-Guzik A, Allen C J Cheminform. 2024; 16(1):117.

PMID: 39468626 PMC: 11520512. DOI: 10.1186/s13321-024-00911-3.


Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke.

Ye J, Bi X, Deng S, Wang X, Liu Z, Suo Q Theranostics. 2024; 14(15):6071-6087.

PMID: 39346547 PMC: 11426240. DOI: 10.7150/thno.100090.


Systematic Insights into the Relationship between the Microbiota-Gut-Brain Axis and Stroke with the Focus on Tryptophan Metabolism.

Shen X, Mu X Metabolites. 2024; 14(8).

PMID: 39195495 PMC: 11356289. DOI: 10.3390/metabo14080399.


References
1.
Nguyen Q, Osypuk T, Schmidt N, Glymour M, Tchetgen Tchetgen E . Practical guidance for conducting mediation analysis with multiple mediators using inverse odds ratio weighting. Am J Epidemiol. 2015; 181(5):349-56. PMC: 4339385. DOI: 10.1093/aje/kwu278. View

2.
Larsson S, Wallin A, Wolk A . Dietary Approaches to Stop Hypertension Diet and Incidence of Stroke: Results From 2 Prospective Cohorts. Stroke. 2016; 47(4):986-90. DOI: 10.1161/STROKEAHA.116.012675. View

3.
Tahir U, Katz D, Zhao T, Ngo D, Cruz D, Robbins J . Metabolomic Profiles and Heart Failure Risk in Black Adults: Insights From the Jackson Heart Study. Circ Heart Fail. 2021; 14(1):e007275. PMC: 9158510. DOI: 10.1161/CIRCHEARTFAILURE.120.007275. View

4.
Zakai N, Judd S, Alexander K, McClure L, Kissela B, Howard G . ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study. J Thromb Haemost. 2014; 12(4):564-70. PMC: 4913462. DOI: 10.1111/jth.12507. View

5.
Chaudhary N, Bridges Jr S, Saag K, Rahn E, Curtis J, Gaffo A . Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. Hypertension. 2019; 75(1):246-256. PMC: 7122733. DOI: 10.1161/HYPERTENSIONAHA.119.13580. View